Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics announced issuance of 18,600 restricted stock units (RSUs) to three newly hired non-executive employees under its 2025 Inducement Equity Plan, following Nasdaq Listing Rule 5635(c)(4). The RSUs vest gradually over several years contingent upon continued employment. Entrada is a clinical-stage biopharmaceutical company developin…